Riskpilot← Back to searchSign inGet full accessY Vitamins AB
ABIn liquidationOrg 5591575039Retail sale via mail order houses or via Internet · NACE 4791Est. 20181 employees
Revenue 2020
SEK 118K
+521% vs 2019
EBITDA margin
-798.3%
+9% vs 2019
Equity ratio
67.9%
Financial strength
Net profit 2020
SEK -942K
+9% vs 2019
| Revenue | SEK 118K | +521% |
| EBITDA | SEK -942K | +9% |
| Net profit | SEK -942K | +9% |
| Total assets | SEK 78K | -92% |
| Equity | SEK 53K | -94% |
| Employees | 1 | — |
Legal name
Y Vitamins AB
Org number
5591575039
Legal form
Aktiebolag
NACE code
4791 · Retail sale via mail order houses or via Internet
Founded
30 april 2018
Share capital
SEK 61 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva import, export och försäljning med hälsoprodukter, äga och förvalta fast och lös egendom (såsom värdepapper) samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 |
|---|---|---|---|
| Revenue | 0 | 19 | 118 |
| Staff expenses | — | — | — |
| EBITDA | −74 | −1 030 | −942 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −74 | −1 030 | −942 |
| Net financials | — | — | — |
| Profit before tax | −74 | −1 030 | −942 |
| Tax | −0 | −0 | −0 |
| Net profit | −74 | −1 030 | −942 |
| Item | 2018 | 2019 | 2020 |
|---|---|---|---|
| Total assets | 1 976 | 979 | 78 |
| Equity | 1 976 | 946 | 53 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 0 | 34 | 24 |
| Total debt | — | 34 | 24 |
EBITDA margin
-798.3%
This company
15.8%
Market median
-5153% vs market
20182020
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20182020
Return on equity
-1777.4%
This company
18.4%
Market median
-9760% vs market
20182020
Net profit margin
-798.3%
This company
8.1%
Market median
-9956% vs market
20182020
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20182020
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20182020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-04-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
OS Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
JC Liquidator | Liquidator | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Y Vitamins AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Oscar Staffan Mac Berlin | Chief Executive Officer | 0 companies |
| Jenny Christina Margaretha Rundgren | Liquidator | 0 companies |
| Nina Louise Almgren | Board of Directors | 0 companies |
| Maria Eva Bellak | Deputy Board Member | 0 companies |
| Viktor Maximilian Bellak | Chairman | 0 companies |